Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xianyin Liang
Institutions:
Fifth Affiliated Hospital of Zhengzhou University,
Third Affiliated Hospital of Zhengzhou University
Observed institutions:
Zhengzhou University,
Fifth Affiliated Hospital of Zhengzhou University,
Third Affiliated Hospital of Zhengzhou University
ORCID:
0000-0001-5771-3106
Observed ORCID:
0000-0001-5771-3106
OpenAlex ID:
A5113019565
Identification and validation of SOCS1/2/3/4 as potential prognostic biomarkers and correlate with immune infiltration in glioblastoma
2023
·
Lirui Dai
, Yongjie Han
, et al.
·
Journal of Cellular and Molecular Medicine
·
15
PDF
Autophagy‐related CMTM6 promotes glioblastoma progression by activating Wnt/β‐catenin pathway and acts as an onco‐immunological biomarker
2024
·
Lirui Dai
, Jingjia Xiao
, et al.
·
The Journal of Gene Medicine
·
7
Advancements and perspectives of RBX2 as a molecular hallmark in cancer
2023
·
Yiran Tao
, Lirui Dai
, et al.
·
Gene
·
7
RNF7‐Mediated ROS Targets Malignant Phenotype and Radiotherapy Sensitivity in Glioma With Different IDH1 Genotypes
2025
·
Yiran Tao
, Zimin Shi
, et al.
·
Molecular Carcinogenesis
·
2
PDF
PRCP could serve as a prognostic biomarker for glioma
2025
·
Xianyin Liang
, Junqi Li
, et al.
·
Asian Journal of Surgery
PIN4 could function as a prognostic biomarker for glioma
2024
·
Xianyin Liang
, Junqi Li
, et al.
·
Asian Journal of Surgery
Rbx2-Mediated ROS Targets Malignant Phenotype and Radiotherapy Sensitivity in Glioma with Different Idh1 Genotypes
2024
·
Xinjun Wang
, Yiran Tao
, et al.
·
SSRN Electronic Journal
Show more works
View as search
Works count:
7
Citation count:
31
H-index:
3
I10-index:
1
Year
Topic
Type